What could possible go wrong?

Exploiting Transgenders Part 2: Medical Engineering Origins
Corey's Digs | Nov 18, 2019

[snip]

The manufacturing of an industry by those exploiting transgenders, far exceeds what most could have conjured up in their wildest imagination. A historical timeline and the social engineering is detailed in part one of this report, and is absolutely mandatory reading before continuing below. What is happening in our country and all around the world has already crossed into dangerous territory, with children as their target. This is a billion dollar industry growing at rapid pace, and if people don’t see the writing on the wall, there is no turning back.

Puberty blockers are being used by physicians around the globe to transition children, which can lead to chemical castration and sterilization as well as a myriad of other side effects. This is the precursor to moving toward gender reassignment surgery. Where did these puberty blockers originate from, are they FDA licensed, and how did science play their role in this?

Dr. Paul McHugh, a distinguished professor of psychiatry and behavioral sciences at Johns Hopkins University, recently told the College Fix:

“Many people are doing what amounts to an experiment on these young people without telling them it’s an experiment. You need evidence for that and this is a very serious treatment. It is comparable to doing frontal lobotomies.

I believe it will be something like how we think of eugenics now. We will come to regret it when we discover how many of the young people that were injured regret it themselves.”

Medical Engineering Origins

In 1969, Marshall and Tanner published the results of their study of 192 white British girls. They claimed that the average age of thelarche (onset of secondary breast development, whereas the initial growth occurs in fetal development) was eleven years and they defined “precocious puberty” in girls if this began before age eight. For boys, it’s if pubertal development occurs before age 9. What does this effect? Primarily, ones height. They could have a growth spurt to grow taller more quickly, then it stops, so when full grown they may be on the shorter side. It certainly wouldn’t put them out of the “norm,” but they’ve programmed a society based on vanity, so being slightly shorter is unacceptable.

With girls, they may begin to develop breasts a few years earlier than their friends. With boys, their penis may begin to grow slightly faster than the average boy. In all cases, NONE of this has a negative health impact on the child. It doesn’t physically harm them, their organs, their bones, or their tissue. It comes down to vanity. Being as 1 in 5,000 – 10,000 children allegedly have “central precocious puberty,” it would seem that society would look upon this as “normal,” especially considering there are a lot of fairly short people in this world. Who really cares? They do, because they can monopolize on it, by suggesting it is a disorder. What happened next?

Immediately, scientists set out to find the genes to prevent this from happening. Miraculously, just two years later, in 1971, there was a discovery and synthesis of gonadotropin-releasing hormone (GnRH) by two research teams, Andrew Shally of the New Orleans Institute Laboratory, and Roger Guillemin from the Salk Institute in California. They devised analogs that led to a Nobel Prize in 1977. This is what is used for puberty blockers, under the guise of a “disorder,” so it could be used for transgender transitioning in the future.